Oppenheimer Adjusts Achieve Life Sciences Price Target to $18 From $21, Maintains Outperform Rating

-- Achieve Life Sciences has an average rating of Buy and price targets ranging from $18 to $56, according to analysts polled by Capital IQ.


Price: 4.11, Change: -1.34, Percent Change: -24.59
...

Related Keywords

,Life Sciences Inc ,Achieve Life Sciences ,Markets ,